Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 23 24 25 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
CRISPR Therapeutics–New Enterprise Associates: investment, 201504 financing round totalling Series A $35m + Series B $29m incl new investor NEA 2015-04-29
CRISPR Therapeutics–SEVERAL: investment, 201504 financing round Series A $35m + Series B $29m from SR One + Celgene + NEA + Abingworth + Versant 2015-04-29
CRISPR Therapeutics–Versant Ventures: investment, 201504 financing round totalling Series A $35m + Series B $29m incl founding investor Versant 2015-04-29
Cytena–High-Tech Gründerfonds: investment, 201504 seed financing round totalling €1.1.m from HTGF + a private investor 2015-04-29
Cytena–SEVERAL: investment, 201504 seed financing round €1.1.m from HTGF + a private investor 2015-04-29
Epigenomics–EU (govt): grant, 201504– Horizon 2020 grant €2.77m to validate lung cancer biomarkers in blood plasma 2015-04-29
Facio Therapies–Evotec: drug discovery services, 201504– supply screening service €na to identify drug for muscular wasting disease FSHD 2015-04-29
Lunaphore–Redalpine: investment, 201504 financing round Series A totalling CHF2m inc lead investor Redalpine 2015-04-29
Lunaphore–SEVERAL: investment, 201504 financing round Series A CHF2m led by Redalpine plus private investors from CH + GB 2015-04-29
Novartis–PeptiDream: drug discovery technology, 201504– license non-excl for use of PDPS technology by Novartis 2015-04-29
Univ Utrecht–Bruker Corp: mass spectrometer, 201504 supply existent UMC Utrecht has beeen using MALDI Biotyper for years 2015-04-27
Biofrontera–SEVERAL: investment, 201504–201505 open offer + private placement €3.1m w 2.173m new shares at €2.3/share 2015-04-23
Indivumed–Sysmex: molecular diagnostics, 201504– excl distribution of OncoBEAM CLIA lab services in DACH region by IndivuTest GmbH 2015-04-22
Univ Oslo–Medigene: DC vaccine, 201504 collab existent compassionate use in academic clinical studies in solid tumours by Oslo Univ Hospital 2015-04-20
BioOutsource–Sartorius: investment, 201504 acquisition €na by Sartorius Stedim Biotech 2015-04-17
Formycon–SEVERAL: investment, 201504 capital increase €11.1m with 435.9k new shares at €25.5/share to instituional investors + family offices 2015-04-16
Omeicos–MacDougall Biomedical Communications: public relations, 201504 service existent by MacDougall 2015-04-15
Omeicos–SEVERAL: investment, 201504 financing round Series A €6.2m led by Vesalius Biocapital II 2015-04-15
Menarini–4SC: resminostat, 201504– collab license + developm €95m upfront + milestones + royalties for Asia-Pacific excl JP Menarini Asia-Pacific 2015-04-14
Boehringer–Hydra Biosciences: TRP inhibitors, 201504– collab drug discovery small-molecule TRP inhibitors for renal diseases 2015-04-13
CAPP Medical–Roche: investment, 201504 acquisition by Roche 2015-04-13
Accovion–Clinipace: investment, 201504 acquisition of Accovion from HeidelbergCapital + Creathor Venture + management 2015-04-10
Biofrontera–Maschmeyer Group: investment, 201404 DIVESTMENT Maschmeyer sells 1m remaining shares to existing institutional investors of Biofrontera 2015-04-08
Blueberry Therapeutics–SEVERAL: investment, 201504 financing round $1.75m from UK + Swiss investors 2015-04-08
Prothena–SEVERAL: investment, 201504 public offering $122.1m net $114.2m with 3.3m ordinary shares $37/share 2015-04-08
CRISPR Therapeutics–MacDougall Biomedical Communications: public relations, 201504 service existent by MacDougall 2015-04-07
Merck (DE)–Pfizer: cancer drug, 201504– co-promotion of Xalkori in US + CA + JP + FR + DE + IT + ES + GB by Merck 2015-04-07
Nabriva–SEVERAL: investment, 201504 financing round Series B 1st tranche $50m of total $120m Series B led by Vivo Capital + OrbiMed 2015-04-07
Wilex–SEVERAL: investment, 201504 capital increase €4.16m with 1.5m new shares €2.8/share 2015-04-07
BMS–Uniqure: gene therapy, 201504– collab strategic alliance to develop gene therapy for cardiovascular diseases 2015-04-06
Hichrom–BIA Separations: chromatography, 201504– distribution of CIM monolyth columns in UK by Hichrom Ltd 2015-04-06
AMP Biosimilars–MC Services: public relations, 201504 service existent by MC Services AG 2015-04-02
Caribou Biosciences–SEVERAL: investment, 201504 financing round Series A $11m incl Fidelity Biosciences + Novartis + Mission Bay Capital et al 2015-04-02
Basilea–Univ London: panRAF kinase inhibitors, 201504– license ww excl to oral panRAF kinase inhibitors from ICR + CRT + Wellcome Trust et al 2015-04-01
Innovative Medicines Initiative–Bayer: cancer biomarker, 201504– collab Bayer HealthCare is coordinating partner of CANCER-ID project 2015-04-01
Innovative Medicines Initiative–EU (govt): grant, 201504– funding FP7 €6.3m for CANCER-ID project by IMI of €14.5m total budget 2015-04-01
Innovative Medicines Initiative–Univ Hamburg: cancer biomarker, 201504– collab UKE is coordinating partner of CANCER-ID project 2015-04-01
Merck (DE)–Medicines for Malaria Venture: antimalarial drug, 201504– acquisition rights to DDD107498 by Merck Serono 2015-04-01
Sanofi–Evotec: investment, 201504 acquisition of Sanofi’s site in Toulouse renamed Evotec (France) SAS 2015-04-01
Univ Bayreuth–Bruker Corp: NMR magnet, 201504 supply installation of Ascend Aeon 900 MHz magnet at Research Center for Bio-Macromolecules 2015-04-01
Bayer–MIT: personalised cardiovascular drugs, 201503– collab €na cardiovascular genomics + drug discovery with Broad Institute 2015-03-31
Sonormed–Hamburg (govt): investment, 201503 financing round Series A co-led by HTGF + Innovationsstarter Fonds Hamburg 2015-03-31
Sonormed–High-Tech Gründerfonds: investment, 201503 financing round Series A co-led by HTGF + Innovationsstarter Fonds Hamburg 2015-03-31
Sonormed–SEVERAL: investment, 201503 financing round Series A co-led by HTGF + Innovationsstarter Fonds Hamburg 2015-03-31
vivoPharm–Protea Biosciences: investment, 201503–201601 acquisition $12m in cash + shares subject to raising necessary financing NOT REALISED 2015-03-31
AbbVie–BioMed X: pharma research, 201503– collab €na new BioMed X research group to discover Alzheimer’s treatment 2015-03-30
Aduro Biotech–Novartis: investment, 201503 initial equity investment of $25m as part of alliance w addit $25m commited at future date 2015-03-30
Merck (DE)–Intrexon: cancer immunotherapy, 201503– collab + license excl $115m upfront + $826m milestones + royalties CAR-T cancer therapies 2015-03-30
Novartis–Aduro Biotech: cancer immunotherapy, 201503– strategic alliance $200m upfront + $25m investment + profit sharing + royalties STING agonists 2015-03-30
Analytik Jena–SEVERAL: investment, 201503 DELISTING from regulated market of Frankfurt Stock Exchange 2015-03-26
Apceth–MacDougall Biomedical Communications: public relations, 201503 service existent by MacDougall Munich Office 2015-03-26
Asahi Kasei–Evotec: drug discovery, 201503– supply service €na screening for inhibitors of ion channel targets 2015-03-26
Biocartis–Microbiome: molecular diagnostics, 201503– collab developm intergrated multiplex RT-PCR sepsis test on Idylla platform 2015-03-26
Sumitomo–Evolva: agri bioactives, 201503– collab excl developm + commercialisation of ingredient class by Valent BioSciences 2015-03-26
Mologen–SEVERAL: investment, 201503–201504 capital increase €28.3m with 5.66m new shares at €5/share 2015-03-24
Rigontec–Forbion: investment, 201503 financing round Series A 2nd closing totalling €4.8m from Forbion Capital + Sunstone Capital 2015-03-24
Rigontec–SEVERAL: investment, 201503 financing round Series A 2nd closing €4.8m from Forbion Capital + Sunstone Capital 2015-03-24
Rigontec–Sunstone Capital: investment, 201503 financing round Series A 2nd closing totalling €4.8m from Forbion Capital + Sunstone Capital 2015-03-24
Genetrix (ES)–CR Comunicacion: public relations, 201503 service existent for Sygnis by CR Comunicacion 2015-03-23
HalioDx–SEVERAL: investment, 201503 financing round Series A €7.5m for founding as MBO from Qiagen Marseille 2015-03-23
Joint Polish Investment Fund–SEVERAL: investment, 201503 first $42m closing of JPIF I supported by NCBR 2015-03-23
Sanofi–Evotec: drug discovery, 201503– collab strategic alliance 5 years minimum €250m with €40m upfront 2015-03-20
GATC Biotech–Qiagen: genomic s/w, 201503– license to Ingenuity Variant Analysis s/w + integration w InView Human Exome 2015-03-19
Sigma-Aldrich–Roche: biochemical reagents, 201503– distribution ww excl of Roche biochemical reagents portfolio 2015-03-19
Sopachem–Genetrix (ES): nucleic acid amplification technology, 201503– distribution of Sygnis TruePrime products in Belgium 2015-03-19
Bayer–Genedata: bioinformatics, 201503– supply + collab developm cell line development (CLD) data platform Bayer Pharma 2015-03-17
Merck (DE)–SEVERAL: credit, 201503–201703 US bond $250m 2y floating rate w 0.35% spread over 3-month USD LIBOR EMD Finance LLC 2015-03-17
Merck (DE)–SEVERAL: credit, 201503–201803 US bond $400m 3y coupon of 1.7% EMD Finance LLC 2015-03-17
Merck (DE)–SEVERAL: credit, 201503–202003 US bond $750m 5y coupon of 2.4% EMD Finance LLC 2015-03-17
Merck (DE)–SEVERAL: credit, 201503–202203 US bond $1b 7y 2.95% EMD Finance LLC 2015-03-17
Merck (DE)–SEVERAL: credit, 201503–202503 US bond $1.6b 10y 3.25% EMD Finance LLC 2015-03-17
NEO New Oncology–SEVERAL: investment, 201503 financing round €na to prepare market launch of NEOliquid blood test 2015-03-17
AdnaGen–Qiagen: investment, 201503 acquisition of assets by Qiagen via newly established Qiagen Hannover GmbH 2015-03-16
Boehringer–Artes Biotechnology: vaccine technology, 201503– collab using Hansenula expression system + Metavax platform for animal vaccine development 2015-03-16
Selvita–Bruker Corp: mass spectrometer, 201503 supply existent use of microflex LT MALDI-TOF MS system by Selvita 2015-03-16
Selvita–Thermo Fisher: mass spectrometer, 201503 supply existent use of LC/MS/TSQ system by Selvita 2015-03-16
Tokai Pharmaceuticals–Qiagen: molecular companion diagnostics, 201503– collab developm + commercialistion of CTC-based CDx for galeterone 2015-03-16
United States (govt)–Lumora: nucleic acid purification, 201503– supply of Heat Elution technology to a number of US Govt Departments 2015-03-16
Monarch Catalyst–Evonik: investment, 201503– acquisition 100% €na ANNOUNCED 2015-03-11
EMBL–Ingeniatrics: Cellena bio-encapsulation device, 201503 supply acquisition of device by EMBL 2015-03-10
Merck (DE)–Agilent: companion diagnostics, 201503 collab existent of Merck Serono + Dako 2015-03-10
Merck (DE)–Illumina: molecular diagnostics, 201503– collab strategic alliance ww for sequencing-based cancer tests Merck Serono 2015-03-10
Ozyme–Genetrix (ES): nucleic acid amplification technology, 201503– distribution non-excl of Sygnis TruePrime products in France by Ozyme 2015-03-10
Addex–SEVERAL: investment, 201503 private placement CHF2.8m with 1.53m new shares led by Herculis Partners SA 2015-03-09
Bayer–ACD/Labs: cheminformatics tools, 201503 supply existent customer Bayer CropScience 2015-03-09
Roche–ACD/Labs: cheminformatics tools, 201503 supply existent customer Hoffmann-LaRoche 2015-03-09
Wageningen Univ–Thermo Fisher: mass spectrometer, 201503 supply existent Hans Mol RIKILT Wageningen UR early access user of Q Exactive Focus 2015-03-09
Arrowhead–Novartis: RNAi technology, 201503 acquisition $10m cash + $25m shares + milestones + royalties of entire RNAi RnD portfolio 2015-03-05
CureVac–Gates Foundation: investment, 201503 equity investment €46m by Gates Foundation 2015-03-05
CureVac–Hopp Group: investment, 201503 equity investment €21m by dievini Hopp BioTech Holding 2015-03-05
CureVac–SEVERAL: investment, 201503 private placement €67m from Gates Foundation + dievini Hopp BioTech 2015-03-05
Analyticon Biotechnologies–908 Devices: mass spetrometer, 201503– distribution of M908 MS system by Analyticon in DACH region 2015-03-04
SuppreMol–Baxter: investment, 201503 acquisition for €200m before working capital + other adjustments by Baxter BioScience Business 2015-03-04
Aerodyne–Tofwerk: mass spectrometer, 201503 supply existent OEM of ToF MS systems for Aerodyne products 2015-03-03
Ionicon–Tofwerk: mass spectrometer, 201503 supply existent OEM of ToF MS systems for Ionicon products 2015-03-03
Pfizer–Genedata: bioinformatics, 201503– supply license to Genedata Biologics enterprise platform for Pfizer RnD Sites in US + Europe 2015-03-03
Danaher–Berlin (govt): MS compound library, 201503– collab developm hybrid Q-TOF MS/MS reference library for forensics by Sciex + Labor Berlin 2015-03-02
Imevax–Germany (govt): investment, 201503 KfW invests in 2nd closing of Series A financing 2015-03-02
Albiogen–Illumina: DNA sequencing technology, 201503– distribution of Illumina platforms + solutions in RU + Belarus + Kazakhstan by Albiogen 2015-03-01
APR Applied Pharma Research–HBM: investment, 201503 acquisition of €na minority stake by HBM Partners 2015-03-01
next pagenext page 1 2 3 ... 23 24 25 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

» top